Department of Obstetrics and Gynecology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA.
Matern Child Health J. 2021 Oct;25(10):1562-1573. doi: 10.1007/s10995-021-03152-0. Epub 2021 May 10.
To examine recent rates of long-acting and permanent methods (LAPM) of contraception use during delivery hospitalization and correlates of their use.
A retrospective cohort study utilizing the 2012-2016 National Inpatient Sample of hospitalizations in the United States of America. The International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes were used to identify deliveries, inpatient long-acting reversible contraception (IPP LARC), and postpartum tubal ligation (PPTL). We conducted univariable and multivariable logistic regression to examine associations between demographic, clinical, hospital and geographical characteristics with likelihood of LAPM including IPP LARC and PPTL.
Our sample included 3,642,328 unweighted deliveries. The rate of IPP LARC increased from 34.6 to 54.9 per 10,000 deliveries (58.7%), while the rate of PPTL utilization decreased from 719.5 to 671.8 per 10,000 deliveries (6.6%) over the study period. In multivariable analysis of LAPM utilization versus neither, cesarean delivery (aOR 7.25, 95% CI 7.08-7.43) was associated with greater utilization. Native American (aOR 4.01, 95% CI 2.91-5.53) race was associated with increased use of IPP LARC compared to a non-long-acting method of contraception. Age between 18 and 29 years (aOR 6.21, 95% CI 5.42-7.11) was associated with greater use of IPP LARC versus PPTL. Delivering in a rural hospital ((aOR 0.09, 95% CI 0.06-0.12) and cesarean delivery (aOR 0.09, 95% CI 0.06-0.12) were associated with greater use PPTL versus IPP LARC.
The IPP LARC rate remains at less than 10% the PPTL rates in our study timeframe. The demonstrated variation in uptake of highly effective methods of contraception inpatient after delivery offer possible opportunities for better understanding and improvement in access.
调查美国分娩住院期间长效和永久性避孕方法(LAPM)的近期使用率及其使用的相关因素。
本研究使用了美国 2012-2016 年全国住院患者抽样调查的回顾性队列研究。采用国际疾病分类第 9 版和第 10 版临床修正版代码来识别分娩、院内长效可逆避孕(IPP LARC)和产后输卵管结扎(PPTL)。我们进行了单变量和多变量逻辑回归分析,以研究人口统计学、临床、医院和地理特征与 LAPM(包括 IPP LARC 和 PPTL)使用的可能性之间的关联。
我们的样本包括 3642328 例未加权分娩。IPP LARC 的使用率从每 10000 例 34.6 例增加到 54.9 例(58.7%),而 PPTL 的使用率从每 10000 例 719.5 例下降到 671.8 例(6.6%)。在 LAPM 使用率与非 LAPM 使用率的多变量分析中,剖宫产(aOR 7.25,95%CI 7.08-7.43)与更高的使用率相关。与非长效避孕方法相比,美国原住民(aOR 4.01,95%CI 2.91-5.53)种族与 IPP LARC 的使用增加相关。18-29 岁年龄组(aOR 6.21,95%CI 5.42-7.11)与 IPP LARC 的使用增加相关,而非 PPTL。在农村医院分娩(aOR 0.09,95%CI 0.06-0.12)和剖宫产(aOR 0.09,95%CI 0.06-0.12)与 IPP LARC 相比,PPTL 的使用率更高。
在我们的研究时间段内,IPP LARC 的使用率仍然不到 PPTL 使用率的 10%。分娩后住院期间高效避孕方法的使用率存在差异,这为更好地理解和改善获取途径提供了可能的机会。